Fonseca Biosciences has launched XTORO (finafloxacin otic suspension) 0.3% in [...]

Merck has received FDA Breakthrough Therapy designation for enpatoran, an [...]

Alamar Biosciences has launched what it describes as the first [...]

FORE Biotherapeutics has completed target enrolment in the primary central [...]

A peer-reviewed study published in Therapeutic Innovation & Regulatory Science [...]

Compass Pathways has reported positive six-month results from its second [...]

Healome Therapeutics has raised £2 million in seed funding to [...]

Xeltis has completed the first commercial implantation of its aXess [...]

EnteroBiotix has dosed the first patient in its Phase 2b [...]

Cyllene Therapeutics has raised €33 million in a Series C [...]